This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Verheyden, S. L. Articles by Curran, H. V. Search for Related Content PubMed PubMed Citation Articles by Verheyden, S. L. Articles by Curran, H. V. Social Bookmarking                         What's this?

Quitting Ecstasy: An Investigation of Why People Stop Taking the Drug and Their Subsequent Mental Health

Rachel Maidment

H. Valerie Curran

Clinical Psychopharmacology Unit, Clinical Health Psychology, University College London, London, UK.v.curran{at}ucl.ac.uk

The regular use of ecstasy (3,4-methylenedioxymethamphetamine, MDMA) has been associated with depressed mood, anxiety and hostility, but it is not known whether such effects persist after people stop using the drug. Furthermore, little is known about what factors might influence the decision to quit using MDMA. The aim of the present study was to examine the reasons why ex-users had stopped using this drug and to assess their current levels of depression, anxiety, anger and aggression. Telephone interviews were conducted with people who used to take MDMA on a regular basis but who no longer used the drug. The participants comprised sixty-six ex-users who used to take MDMA regularly (at least once every 2 months over a period of at least 1 year), but who had not taken MDMA for at least 1 year (average 3 years). Participants were asked about why they had quit MDMA. They also completed questionnaires to assess trait mood.Ex-users could be divided into two groups based on their reason for quitting: (i) those who had quit for mental health reasons and (ii) those who had quit for circumstantial reasons. Approximately half of those in the mental health group scored in the range for clinical depression. In that group, current levels of depression and anxiety correlated significantly with the cumulative amount of MDMA that they had taken several years previously. These findings suggest that some users may either be more vulnerable to the adverse effects of MDMA or have pre-existing mental health problems for which they self-medicate by using ecstasy. The present study shows that some ex-users experience an impairment to mental health that persists for years after they stop using this drug.

Key Words: aggression • depression • ecstasy • ex-users • MDMA

Journal of Psychopharmacology, Vol. 17, No. 4, 371-378 (2003)
DOI: 10.1177/0269881103174014


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K Soar, A Parrott, and J Turner Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users J Psychopharmacol, September 1, 2009; 23(7): 745 - 758. [Abstract] [PDF]

				R. Buchert, F. Thiele, R. Thomasius, F. Wilke, K. Petersen, W. Brenner, J. Mester, L. Spies, and M. Clausen Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling? J Psychopharmacol, August 1, 2007; 21(6): 628 - 634. [Abstract] [PDF]

				R. W. Freudenmann, C. Schonfeldt-Lecuona, M. Spitzer, L. Hermle, and G. Gron Electroconvulsive therapy in the treatment of depression in a former ecstasy user J Psychopharmacol, November 1, 2006; 20(6): 860 - 862. [Abstract] [PDF]

				A. P. Hall and J. A. Henry Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management Br. J. Anaesth., June 1, 2006; 96(6): 678 - 685. [Abstract] [Full Text] [PDF]

				A. C Huizink, R. F Ferdinand, J. van der Ende, and F. C Verhulst Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study BMJ, April 8, 2006; 332(7545): 825 - 828. [Abstract] [Full Text] [PDF]

				A. C. Parrott Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy J Psychopharmacol, January 1, 2005; 19(1): 71 - 83. [Abstract] [PDF]